Cargando…
Deregulated expression of HDAC9 in B cells promotes development of lymphoproliferative disease and lymphoma in mice
Histone deacetylase 9 (HDAC9) is expressed in B cells, and its overexpression has been observed in B-lymphoproliferative disorders, including B-cell non-Hodgkin lymphoma (B-NHL). We examined HDAC9 protein expression and copy number alterations in primary B-NHL samples, identifying high HDAC9 express...
Autores principales: | Gil, Veronica S., Bhagat, Govind, Howell, Louise, Zhang, Jiyuan, Kim, Chae H., Stengel, Sven, Vega, Francisco, Zelent, Arthur, Petrie, Kevin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5200892/ https://www.ncbi.nlm.nih.gov/pubmed/27799148 http://dx.doi.org/10.1242/dmm.023366 |
Ejemplares similares
-
The Therapeutic Strategy of HDAC6 Inhibitors in Lymphoproliferative Disease
por: Cosenza, Maria, et al.
Publicado: (2018) -
KRAS and RAS-MAPK Pathway Deregulation in Mature B Cell Lymphoproliferative Disorders
por: Vendramini, Elena, et al.
Publicado: (2022) -
Dual inhibition of EZH2 and G9A/GLP histone methyltransferases by HKMTI-1-005 promotes differentiation of acute myeloid leukemia cells
por: Sbirkov, Y., et al.
Publicado: (2023) -
Semi-Quantitative Mass Spectrometry in AML Cells Identifies New Non-Genomic Targets of the EZH2 Methyltransferase
por: Sbirkov, Yordan, et al.
Publicado: (2017) -
CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk
por: Baer, Constance, et al.
Publicado: (2022)